Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 4
1949 5
1951 3
1952 5
1953 2
1954 5
1955 6
1956 5
1957 2
1958 8
1959 2
1961 9
1962 15
1963 16
1964 15
1965 18
1966 22
1967 31
1968 26
1969 39
1970 33
1971 21
1972 26
1973 24
1974 34
1975 33
1976 21
1977 21
1978 33
1979 38
1980 49
1981 53
1982 71
1983 79
1984 95
1985 104
1986 107
1987 111
1988 127
1989 139
1990 151
1991 150
1992 130
1993 124
1994 107
1995 141
1996 151
1997 168
1998 191
1999 204
2000 238
2001 205
2002 257
2003 272
2004 310
2005 324
2006 368
2007 386
2008 360
2009 404
2010 395
2011 459
2012 524
2013 528
2014 534
2015 561
2016 566
2017 619
2018 636
2019 631
2020 331
Text availability
Article attribute
Article type
Publication date

Search Results

10,866 results
Results by year
Filters applied: . Clear all
Page 1
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.
Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group. Misawa S, et al. Among authors: Sato Y. Lancet Neurol. 2018 Jun;17(6):519-529. doi: 10.1016/S1474-4422(18)30114-5. Epub 2018 Apr 21. Lancet Neurol. 2018. PMID: 29685815 Clinical Trial.
The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD.
Sato Y, Feig DI, Stack AG, Kang DH, Lanaspa MA, Ejaz AA, Sánchez-Lozada LG, Kuwabara M, Borghi C, Johnson RJ. Sato Y, et al. Nat Rev Nephrol. 2019 Dec;15(12):767-775. doi: 10.1038/s41581-019-0174-z. Epub 2019 Jul 11. Nat Rev Nephrol. 2019. PMID: 31296965 Review.
Climate Change and the Kidney.
Johnson RJ, Sánchez-Lozada LG, Newman LS, Lanaspa MA, Diaz HF, Lemery J, Rodriguez-Iturbe B, Tolan DR, Butler-Dawson J, Sato Y, Garcia G, Hernando AA, Roncal-Jimenez CA. Johnson RJ, et al. Among authors: Sato Y. Ann Nutr Metab. 2019;74 Suppl 3:38-44. doi: 10.1159/000500344. Epub 2019 Jun 14. Ann Nutr Metab. 2019. PMID: 31203298 Free article.
Immunology of the ageing kidney.
Sato Y, Yanagita M. Sato Y, et al. Nat Rev Nephrol. 2019 Oct;15(10):625-640. doi: 10.1038/s41581-019-0185-9. Epub 2019 Sep 2. Nat Rev Nephrol. 2019. PMID: 31477915 Review.
Effect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM Trial.
Tanaka A, Shimabukuro M, Machii N, Teragawa H, Okada Y, Shima KR, Takamura T, Taguchi I, Hisauchi I, Toyoda S, Matsuzawa Y, Tomiyama H, Yamaoka-Tojo M, Yoshida H, Sato Y, Ikehara Y, Ueda S, Higashi Y, Node K; EMBLEM Investigators. Tanaka A, et al. Among authors: Sato Y. Diabetes Care. 2019 Oct;42(10):e159-e161. doi: 10.2337/dc19-1177. Epub 2019 Sep 18. Diabetes Care. 2019. PMID: 31533913 No abstract available.
10,866 results
Jump to page
Feedback